Your favorite songs on psychedelics: a brain study
NCT ID NCT07180108
First seen Nov 01, 2025 · Last updated Jun 21, 2026 · Updated 35 times
Summary
This study gives 100 healthy adults a single 25 mg dose of psilocybin and has them listen to different playlists—some personally meaningful, some standard. Researchers measure brain activity, heart rate, and emotional responses to see if personal music boosts positive effects. The goal is to understand how music influences the psychedelic experience, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSIC INTERVENTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Center for Psychedelics and Consciousness Research in the Behavioral Biology Research Center
Baltimore, Maryland, 21224, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
psilocybin (25 mg pill)
What this could lead to
If it works, this could help design better music-based settings for psychedelic therapy, potentially improving mood and well-being outcomes.
What could go wrong
This is an early Phase 1 study in healthy volunteers, not patients. It focuses on understanding brain responses, not treating any disease. Results may not apply to therapeutic settings.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.